Bio Green Med Solution Inc Preferred Stock
BGMSP
BGMSP was delisted on the 20th of March, 2026.
1 hedge funds and large institutions have $20K invested in Bio Green Med Solution Inc Preferred Stock in 2019 Q3 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 0 reducing their positions, and closing their positions.
82% more capital invested
Capital invested by funds: $11K → $20K (+$9K)
0.65% more ownership
Funds ownership: 0.66% → 1.3% (+0.65%)
0% more funds holding
Funds holding: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$10.9K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $20K | +$10.9K | +2,200 | +99% |
|
BGMSP Hedge Fund Activity: Q3 2019 in Review
1 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Bio Green Med Solution Inc Preferred Stock (BGMSP) for Q3 2019, worth a combined $20K — up 82% from $11K a quarter earlier.
Fund positioning in BGMSP was balanced in Q3 2019: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, adding an estimated $10.9K.
- 1 institutional investor held Bio Green Med Solution Inc Preferred Stock (BGMSP) as of Q3 2019, unchanged from Q2 2019.
- Funds reported $20K of Bio Green Med Solution Inc Preferred Stock stock for Q3 2019, up 82% quarter-over-quarter.
- 0 funds opened new Bio Green Med Solution Inc Preferred Stock positions in Q3 2019 and 0 closed out.
- The largest Bio Green Med Solution Inc Preferred Stock buyer in Q3 2019 was UBS Group, an estimated $10.9K added.
Based on aggregated 13F filings for Q3 2019.